Trial Profile
A trial of JCAR 024 in patients with solid tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2016
Price :
$35
*
At a glance
- Drugs JCAR 024 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Juno Therapeutics
- 05 Mar 2016 New trial record